A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies.
Eur J Haematol
; 2024 Jul 02.
Article
in En
| MEDLINE
| ID: mdl-38956924
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Eur J Haematol
Journal subject:
HEMATOLOGIA
Year:
2024
Document type:
Article
Affiliation country:
Australia
Country of publication:
United kingdom